New 3-Month shot aims to control hormones in breast cancer
NCT ID NCT04906395
Summary
This study is testing a 3-month injection called TOL2506, which aims to temporarily shut down the ovaries in premenopausal women with a common type of breast cancer. The goal is to see if this injection, when combined with standard hormone-blocking pills, effectively lowers hormone levels that can fuel cancer growth. About 250 participants will receive the injection and be monitored for one year to check its effectiveness and safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Amiisto Atencion Medica Integral, Investigacion Y Terapia Oncologica S.A De C.V.
Mexico City, Mexico City, 07300, Mexico
-
Apollo Cancer Hospitals
Hyderabad, Telangana, 500096, India
-
Apollo Hospitals
Visakhapatnam, Andhra Pradesh, 530040, India
-
Baptist Health Louisville
Louisville, Kentucky, 40207, United States
-
Centro Privado de RMI Rio Cuarto
Río Cuarto, Córdoba Province, 5800, Argentina
-
Centro Regional Integrado de Oncologia
Fortaleza, Ceará, 60335-480, Brazil
-
Centro de Estudos e Pesquisas de Hematologia e Oncologia da Faculdade de Medicina do ABC
Santo André, São Paulo, 09060-650, Brazil
-
Clinica EMA
Mexico City, 03339, Mexico
-
Clinica de Pesquisa e Centro de Estudos em Oncologia Ginecologica e Mamaria
São Paulo, São Paulo, 01317-001, Brazil
-
Cypress Hematology and Oncology
Parker, Colorado, 80138, United States
-
Erode Cancer Centre Private Ltd.
Erode, Tamil Nadu, 638012, India
-
FAICIC S. de R.L. de C.V.
Veracruz, 91900, Mexico
-
FDI Clinical Research
San Juan, 00927, Puerto Rico
-
Fundacao Pio XII
Barretos, São Paulo, 14784-400, Brazil
-
Fundacion CENIT
CABA, C1125ABD, Argentina
-
HCG Cancer Centre
Visakhapatnam, Andhra Pradesh, 530040, India
-
HCG City Cancer Centre
Vijayawada, Andhra Pradesh, 520002, India
-
HCG Manavata Cancer Centre
Nashik, Maharashtra, 42202, India
-
Hemato Oncology Clinic Ahmedabad Pvt. Ltd.
Ahmedabad, Gujarat, 380054, India
-
Hospital Aleman
Buenos Aires, C118AAT, Argentina
-
Hospital Araujo Jorge
Goiânia, Goiás, 74605-070, Brazil
-
Hospital Britanico de Buenos Aires
Buenos Aires, Buenos Aires F.D., C1480AEB, Argentina
-
Hospital Provincial del Centenario
Rosario, Santa Fe Province, S2000KDS, Argentina
-
Hospital Sao Rafael
Salvador, Estado de Bahia, 41253-190, Brazil
-
Hospital de Amor Amazonia
Porto Velho, Rondônia, 76834-899, Brazil
-
Hospital do Cancer de Londrina
Londrina, Paraná, 86015-520, Brazil
-
Indrayani Hospital and Cancer Institute
Pune, Maharashtra, 412105, India
-
Instituto Medico de la Fundacion Estudios Clinicos
Rosario, Santa Fe Province, S2000DEJ, Argentina
-
Instituto Oncologico de Cordoba (IONC)
Córdoba, Córdoba Province, 5000, Argentina
-
Instituto de Educacao, Pesquisa e Gestao em Saude
Rio de Janeiro, 22775-001, Brazil
-
Irmamandade de Santa Casa de Misericordia de Porto Alegre
Porto Alegre, 90020-090, Brazil
-
KIMS-Kingsway Hospitals, SPANV Medisearch Lifesciences
Nagpur, Maharashtra, 440001, India
-
Lankenau Medical Center
Wynnewood, Pennsylvania, 19096, United States
-
Marin Cancer Care, Inc
Greenbrae, California, 94904, United States
-
Maryland Oncology Hematology, P.A.
Glenn Dale, Maryland, 20769, United States
-
Montefiore - Einstein Center for Cancer Care at Montefiore Medical Park
The Bronx, New York, 10461, United States
-
Mount Sinai Hospital
Chicago, Illinois, 60608, United States
-
Mysore Medical College and Research Institute
Mysore, Karnataka, 570001, India
-
Nebraska Cancer Specialists
Omaha, Nebraska, 68114, United States
-
Oncocentro Servicos Medicos e Hospitalares Ltda
Fortaleza, Ceará, 60135-237, Brazil
-
Oncology Hematology Care Clinical Trials
Cincinnati, Ohio, 45211, United States
-
Onconeo
Campo Grande, Mato Grosso do Sul, 79002-061, Brazil
-
Oncoville Cancer Hospital and Research Center
Bengaluru, Karnataka, 560072, India
-
Princess Margaret Cancer Centre
Toronto, Ontario, M5G 1Z5, Canada
-
SRV AGADI Hospital and Research Centre
Bengaluru, Karnataka, 560027, India
-
Sanatorio Allende- Sede Nueva Cordoba
Córdoba, X5000JHQ, Argentina
-
Seattle Cancer Center Alliance
Seattle, Washington, 98109, United States
-
Sunnybrook Odette Cancer Centre Clinical Research Program
Toronto, Ontario, M4N 3M5, Canada
-
Swami Harshankaranand Ji Hospital & Research Centre
Varanasi, Uttar Pradesh, 221004, India
-
Tennessee Oncology, PLLC
Chattanooga, Tennessee, 37404, United States
-
Tennessee Oncology, PLLC
Nashville, Tennessee, 37203, United States
-
Texas Oncology- Dallas Presbyterian Hospital
Dallas, Texas, 75231, United States
-
Texas Oncology- Deke Slayton Cancer Center
Webster, Texas, 77598, United States
-
Texas Oncology- Northeast Texas
Tyler, Texas, 75702, United States
-
Texas Oncology- San Antonio
New Braunfels, Texas, 78130, United States
-
Texas Oncology-Austin
Austin, Texas, 78731, United States
-
Uniao Brasileira de Educacao e Assistencia
Porto Alegre, Rio Grande do Sul, 90610-000, Brazil
-
Unidad de Medicina Especializada SMA
San Juan del Río, Querétaro, 76800, Mexico
-
Unique Hospital Multispecialty & Research Institute
Surat, Gujarat, 395002, India
Conditions
Explore the condition pages connected to this study.